Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
Sameer SaleemWaqas UllahMubbasher Ameer SyedMichael MegalyNishanth ThalambeduSundas YounasSalman ZahidMahboob AlamSalim S ViraniDivya Ratan VermaMohammad Abdul-WaheedDavid L FischmanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
ViV-TAVR compared to redo-SAVR appears to be associated with significant improvement in short term mortality and major bleeding. For mid to long-term follow up, the outcomes were similar for both groups.
Keyphrases
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- systematic review
- meta analyses
- cardiovascular events
- atrial fibrillation
- risk factors
- randomized controlled trial
- metabolic syndrome
- mitral valve
- ejection fraction
- adipose tissue
- insulin resistance